Current Health News Briefs: Nestle, Avian Flu in India, Mpox in Uganda, and More
The latest health news includes Nestle maintaining its Health Science unit post-CEO change, an avian flu outbreak in Odisha, India, Uganda confirming more mpox cases, the arrival of mpox vaccines in Africa after two years, and Novartis receiving a binding offer from Siemens Healthineers for its molecular imaging business.
Nestle intends to retain its Health Science unit following the exit of CEO Mark Schneider, as confirmed by Chairman Paul Bulcke. The unit is considered for medium-term sale by some analysts.
An outbreak of avian flu has led to the culling of over a thousand chickens in Odisha, India. The infected area is centered in the Puri district.
Uganda has reported two additional mpox cases, resulting in a total of four confirmed in the country. The clade 1b strain of the virus has caused significant global concern.
Mpox vaccines are set to arrive in Africa next week, addressing the new strain that has been a cause for global alarm. The delayed response highlights existing global healthcare inequities.
Novartis has received a binding offer from Siemens Healthineers to acquire its molecular imaging business, paying over 200 million euros. This acquisition will include Advanced Accelerator Applications' PET scan technology.
(With inputs from agencies.)
- READ MORE ON:
- health news
- Nestle
- avian flu
- Odisha
- mpox
- Uganda
- vaccines
- Novartis
- Siemens
- molecular imaging
ALSO READ
Nigeria Receives 10,000 Mpox Vaccine Doses from USAID
FDA Expands Use of Smallpox Vaccine for Mpox Prevention
Inequitable Access to HPV Vaccines and Screening Tools Hindering Cervical Cancer Elimination in Africa, Warns WHO
Global Health Briefs: Nigeria Receives mpox Vaccine, Mundipharma Sale Falters, Biden's Drug Cap and More
WHO Chief Announces Imminent Arrival of Mpox Vaccines in Congo